Ripasudil
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Ripasudil, covering 2023-02-06 to 2026-08-06. Get the full timeline:
Most recent: Clinical Trial Results: A Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract Surgery [Phase 3]